D-0636-2021 Class II Terminated
FDA drug recall D-0636-2021 was initiated by Teligent Pharma, Inc. on May 14, 2021 and is designated Class II. Reason for recall: Presence of Foreign Substance: Foreign particles observed during routine stability testing. The recall status is terminated (terminated Aug 22, 2022). Affected quantity: 6,240 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 30, 2021
- Initiation Date
- May 14, 2021
- Termination Date
- Aug 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,240 tubes
Product description
Diflorasone Diacetate Ointment USP, 0.05%, packaged in a)15 g (NDC 52565-063-15) and b) 30 g (NDC 52565-063-30) tubes, Rx only, Manufactured by: Teligent Pharma, Inc, Buena, NJ 08310.
Reason for recall
Presence of Foreign Substance: Foreign particles observed during routine stability testing.
Distribution pattern
Nationwide in the United States
Code information
Lot #: 16264, Exp Date Nov 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0636-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026